NeuroScience 2024: Agenda
Alzheimer's disease is a debilitating illness that progressively affects the brain, causing symptoms such as memory loss, confusion, and difficulty communicating. These symptoms may start mildly but can progress over time, eventually leading to severe impairments in daily living activities.
Symptoms of Alzheimer's disease typically include forgetfulness, trouble recalling names, conversations, and recent events. Individuals may also experience difficulty completing familiar tasks, such as driving, cooking, or managing finances. As the disease progresses, individuals may develop mood swings, become withdrawn, and experience changes in personality and behavior.
While there is no known cure for Alzheimer's disease, there are various treatments available that can help manage symptoms and improve quality of life. Medications, such as cholinesterase inhibitors and memantine, can help improve memory and cognitive function. Additionally, lifestyle changes, such as regular exercise, a healthy diet, and mental stimulation, can also help manage symptoms.
However, if left untreated or ignored, the consequences of Alzheimer's disease can be severe. Individuals may experience a decline in cognitive function and may require full-time care. The disease can also take a toll on caregivers, who may experience physical, emotional, and financial strain.
Therefore, it is crucial to continue research and advancements in Alzheimer's disease prevention, early detection, and innovative treatments. Through conferences like the International Live Conference on Alzheimer's Disease, we can continue to bring together experts and professionals from around the world to share knowledge and expertise, and work towards better solutions for individuals and families affected by this devastating disease.
According to the World Health Organization, an estimated 50 million people worldwide live with dementia, with approximately 60-70% of cases being Alzheimer's disease. The number of people living with dementia is expected to triple by 2050, with most of the increase occurring in low- and middle-income countries.
In response to the growing global impact of Alzheimer's disease, the International Live Conference on Alzheimer's Disease has been scheduled for April 27, 2024. The conference theme for this online event is "Frontiers in Research on Alzheimer's Disease."
The conference aims to bring together experts and professionals from around the world to share the latest research and advancements in Alzheimer's disease. Topics to be covered include the latest findings on disease prevention, early detection, and innovative treatments. In addition, the conference will explore the impact of Alzheimer's disease on patients, families, and caregivers, as well as strategies for improving care and support for those affected by the disease.
Through this conference, we hope to advance our understanding of Alzheimer's disease and work towards better solutions for prevention, diagnosis, and treatment. We believe that by sharing our knowledge and expertise, we can make a significant impact on the lives of individuals and families affected by this devastating disease.
Title: The International Live Conference on Alzheimer's Disease
Date: April 27, 2024
Time: 8 PM Indian Standard Time
Location: Online
Conference Theme: Frontiers in Research on Alzheimer's Disease
Deadlines:
To secure your place as a distinguished speaker at this conference, ensure to submit your abstract no later than April 20, 2024.
Alzheimer's Disease previous talks
Alzheimer's Disease 2022
Title: Lapse Memory Deficiency in an Alzheimer’s Disease Model Using Physical and Cognitive Exercise
by Dr. Tshetiz Dahal, Lugansk State Medical University, Ukraine
Alzheimer's Disease 2022
by Prof. Dr. Sampoornam W, Dhanvantri College of Nursing, India
Alzheimer's Disease 2022
by Karthikeyan Selvarasu, Department of Microbiology, Central University of Tamilnadu, India
Alzheimer's Disease 2022
by Ali Haider Bangash, STMU Shifa College of Medicine, Pakistan
Alzheimer's Disease 2022
by Huang Wei Ling, University of Sao Paulo, Brazil
Alzheimer's Disease 2022
Title: Depletion of Endogenous KIF5B Ameliorates Tau hyperphosphorylation, Aggregation and Memory impairment in models of Alzheimer’s Disease
by Elias Mazrooei Rad, Biomedical Engineering Department ,Khavaran Institute of Higher Education, Iran